Montréal, January 21, 2016 – Moleculomics, a company specializing in molecular research for the pharmaceutical, defence and biotech industries, announced the opening of its first North American facility in Greater Montréal. Founded just four years ago in Wales, the U.K.-based company develops computing biosimulation (in silico modelling) tools and data platforms to improve knowledge of molecular interactions in new drugs and chemical compounds.
“Opening an R&D office in Montréal is a great growth opportunity for Moleculomics. Thanks to the support of Montréal International, we will generate six new jobs to assist the commercialization of our in silico screening services,” said Dr. Will Krawszik, Head of Operations and the Montréal office.
Click here for full article.